… look forward to collaborating with ProQR and its exciting RNA editing technologies.” About ProQR ProQR Therapeutics is … Nucleotides”, or EONs, recruit an endogenously expressed RNA editing system called ADAR, which it can direct to change …
… supports ProQR’s strategic focus on the Axiomer® RNA editing technology platform and continued advancement of … “We look forward to continuing to advance our Axiomer RNA editing platform, with an initial focus on targets for …
… scientific advisory board Dr. Yu’s research focuses on RNA editing and his expertise will help to develop the Company’s novel RNA editing technologies Presented at the European Cystic …
… will focus exclusively on the development of its Axiomer RNA editing technology platform across multiple therapeutic … In November, the Company plans to present its proprietary RNA base-editing Axiomer technology at the Oligonucleotide …
… development and further advance our novel Axiomer ® RNA editing platform. With these events we look forward to … ® EONs are designed to recruit an endogenously expressed RNA editing system called ADAR, which can direct the change …